A Phase I Study of NS-079 in Healthy Participants

NCT07669571 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Participants

Interventions

DRUG: Placebo
DRUG: NS-079 tablet
DRUG: Paroxetine

Sponsor

NeuShen Therapeutics